Company Filing History:
11 out of 123 
3 out of 55 
3 out of 10 Years Active: 2017-2025
Title: Innovations by Diana Abdueva: Pioneering Fetal Genetic Analysis
Introduction
Diana Abdueva, an esteemed inventor based in Orinda, California, has significantly contributed to the field of prenatal diagnostics with an impressive portfolio of 14 patents. Her innovative methods have paved the way for non-invasive genetic analysis, providing critical insights into fetal health and disease.
Latest Patents
Among Diana's latest patents is a groundbreaking method for Detecting Fetal Sub-Chromosomal Aneuploidies. This patent discloses advanced techniques for determining copy number variation (CNV) associated with various medical conditions, particularly those related to subchromosomal regions. The patent outlines methods for using maternal samples that contain both maternal and fetal cell-free DNA to assess fetal health.
Another notable patent from Diana involves Methods for Characterizing Cell-Free Nucleic Acid Fragments. This innovation presents systems and techniques for utilizing cell-free nucleic acids (cfNA) for non-invasive disease detection, diagnosis, and monitoring. One significant application includes determining the stage and progression of cancer, as well as assessing the responsiveness to treatments without the need for invasive procedures.
Career Highlights
Diana has demonstrated remarkable expertise while working at leading companies in the healthcare sector. Notable organizations she has been associated with include Guardant Health, Inc. and Verinata Health, Inc. Her experience in these firms reflects her commitment to advancing genetic testing methodologies and improving patient outcomes.
Collaborations
Throughout her career, Diana has collaborated with several accomplished professionals, including Darya Chudova and Stefanie Ann Ward Mortimer. These collaborations have enabled her to enhance her research and development efforts, further establishing her prominence in the field of genetic diagnostics.
Conclusion
Diana Abdueva continues to be at the forefront of innovation in prenatal diagnostics, holding 14 patents that revolutionize how genetic conditions are detected and treated. Her work not only benefits expectant parents but also contributes greatly to the medical community's understanding of fetal genetics. With a proven track record and a commitment to excellence, Diana’s contributions are truly remarkable.